Rankings
▼
Calendar
NAUT Q1 2025 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$339M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$19M
Net Income
-$17M
EPS (Diluted)
$-0.13
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$228M
Total Liabilities
$33M
Stockholders' Equity
$194M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
-$2M
-2.1%
Operating Income
-$19M
-$22M
+12.8%
Net Income
-$17M
-$19M
+11.3%
← FY 2025
All Quarters
Q2 2025 →